-
Product Insights
Lennox-Gastaut Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Lennox-Gastaut Syndrome Clinical Trial Report Overview A total of 254 Lennox-Gastaut Syndrome clinical trials were conducted as of January 2024. The Lennox-Gastaut Syndrome clinical trial report provides a comprehensive understanding of the Lennox-Gastaut Syndrome clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       North...
-
Product Insights
Lennox-Gastaut Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Lennox-Gastaut Syndrome - Drugs In Development, 2023’, provides an overview of the Lennox-Gastaut Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lennox-Gastaut Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Sector Analysis
Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Report Overview Lennox-Gastaut Syndrome (LGS) is a severe form of epilepsy that typically becomes apparent during infancy or early childhood. Affected children experience several different types of seizures, such as atonic, tonic, and atypical absence seizures. Children with LGS may also develop cognitive dysfunction, delays in reaching developmental milestones, and behavioral problems. Key Mechanism of Action (Marketed) ·       Receptor Agonists ·       Ion Channel Blockers ·       Enzyme Inhibitors ·       Receptor Antagonists ·       Transporter Inhibitors...